Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment

BACKGROUND: To evaluate the lifetime secondary cancer risk (SCR) of stereotactic body radiotherapy (SBRT) using the CyberKnife (CK) M6 system with a lung-optimized treatment (LOT) module for lung cancer patients. METHODS: We retrospectively enrolled 11 lung cancer patients curatively treated with SB...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Bioeng Biotechnol
Autors principals: Chao, Pei-Ju, Tsai, I-Hsing, Huang, Chun-Chieh, Lin, Chih-Hsueh, Shieh, Chin-Shiuh, Hsieh, Yang-Wei, Yang, Pei-Ying, Lee, Hsiao-Fei, Lee, Tsair-Fwu
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Bioengineering and Biotechnology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7223476/
https://ncbi.nlm.nih.gov/pubmed/32457880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00306
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars